Moreover, E6AP-low/CDC6-high/P16ink4a-low protein abundance profiles are associated with hypomethylation of the gene encoding P16ink4a (CDKN2A) and poorer prognosis in NSCLC patients (Lim and Townsend, 2020). The gene discussed is CDKN2A; the disease is non-small cell lung carcinoma.